跳至主要内容
临床试验/ISRCTN11966080
ISRCTN11966080已完成未知

A multicentre, double blind, placebo controlled, randomised trial to evaluate the effectiveness of a 1-day versus 7-day regimen of nitrofurantoin for the treatment of asymptomatic bacteriuria in pregnancy

World Health Organization (WHO) (Switzerland)0 个研究点目标入组 778 人开始时间: 2007年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
778

研究概览

简要总结

2009 results in https://pubmed.ncbi.nlm.nih.gov/19155904/ (added 30/12/2020)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant women with gestational age 12 - 32 weeks
  • 2. Willing and able to give consent

排除标准

  • 1. Have any underlying disease, which require continuous steroid and/or antibiotic treatment, e.g. systemic lupus erythematosus, valvular heart disease, etc.
  • 2. Use of any antibiotics during the past one-week
  • 3. Received any treatment for urinary tract infection at any time during the current pregnancy
  • 4. History of nitrofurantoin hypersensitivity
  • 5. Plan not to deliver at the study hospital
  • 6. Any symptoms such as flank pain, dysuria that suggests symptomatic Urinary Tract Infections (UTI)
  • 7. Have any haematological disease including Glucose-6-Phosphate Dehydrogenase deficiency (G6PD)
  • 8. Negative urine dipslide
  • 9. Negative urine culture
  • 10. Positive urine culture but the organism is resistant to Nitrofurantoin

研究者

发起方
World Health Organization (WHO) (Switzerland)

相似试验